RxDoctor Payments Data

Kenneth Guthrie

Optometrist · Oklahoma City, OKNPI 1558414904

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (57.0%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Alk-abello, Inc accounts for 89.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $1,774 and has fallen 97.4% since, to $46 in 2025. Among optometrist clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,945in general payments, 2019–2025

Across 34 payments — averaging $204.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alk-abello, Inc$6K
  • NEW World Medical,inc.$218
  • Johnson & Johnson Vision Care, Inc.$189
  • Glaukos Corporation$151
  • Alcon$112
  • Rxsight Inc$66
  • plus $30 from 1 others

What the payments were for

  • Consulting fees$3,96057%
  • Speaking & faculty fees$2,22032%
  • Food & beverage$76511%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,945 in reported general payments places this provider in the 95th percentile of 714 optometrist providers in Oklahoma.

See all optometrist providers in Oklahoma

Medicare billing

Part B allowed, 2024
$5,818
Medicare patients
23
Services billed
114

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Travoprost34$6,458
Latanoprost89$782

Paid to pharmacies, not to this prescriber.

Other optometrist in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →